<DOC>
	<DOCNO>NCT00389987</DOCNO>
	<brief_summary>This study design compare efficacy ertapenem piperacillin/tazobactam respect clinical response baseline microbiologically evaluable patient ; evaluate tolerability safety ertapenem compare piperacillin/tazobactam .</brief_summary>
	<brief_title>Ertapenem Sodium vs. Piperacillin/Tazobactam Treatment Complicated Intra-Abdominal Infections ( 0826-037 )</brief_title>
	<detailed_description>Original label approve November 2001</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Penicillanic Acid</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Ertapenem</mesh_term>
	<mesh_term>Piperacillin , tazobactam drug combination</mesh_term>
	<criteria>Male female patient ( great equal 18 year age ) Intraoperative/Postoperative Enrollment : Upon visual confirmation intraabdominal infection . Preoperative Enrollment : Patients may enrol preoperatively meet certain criterion Failure meet inclusion criterion . Patients consider unlikely survive 68 week study period . Pregnant nursing woman , fertile woman practice adequate method contraception .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>